Combination of Anti-EGFR and Anti-VEGF Drugs for the Treatment of Previously Treated Metastatic Colorectal Cancer: A Case Report and Literature Review

The standard third-line treatment of metastatic colorectal cancer (mCRC) includes the small-molecule anti-vascular drugs (Regofenib and Fruquintinib) and the chemotherapy drug trifluridine and tipiracil hydrochloride (TAS-102). There is no standard treatment for mCRC if the third-line treatment fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Chen, Xian, Li, Wenzhu, Ye, Yongsong, Du, Xiaohua, Sun, Shaodan, Liu, Lirong, Zhang, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180844/
https://www.ncbi.nlm.nih.gov/pubmed/34109130
http://dx.doi.org/10.3389/fonc.2021.684309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180844/
https://www.ncbi.nlm.nih.gov/pubmed/34109130
http://dx.doi.org/10.3389/fonc.2021.684309

Ejemplares similares